Atlas Trials

the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma

Clinical trial NCT05834751 · UNKNOWN

Trial details

NCT number
NCT05834751
Sponsor
Ou Bai, MD/PHD
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Lymphoma
Start date
2023-05-01
Primary completion
2025-05-01
Enrollment
144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.